Eleison Pharmaceuticals LLC

États‑Unis d’Amérique

 
Quantité totale PI 9
Rang # Quantité totale PI 172 863
Note d'activité PI 1,1/5.0    3
Rang # Activité PI 343 476

Brevets

Marques

5 0
2 0
2 0
0
 
Dernier brevet 2022 - Crystalline polymorphs of 1,6-di...
Premier brevet 2012 - Glufosfamide combination therapi...

Derniers inventions, produits et services

2022 Invention Crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol. Described herein are polymorphic for...
2020 Invention Crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol. Described herein are polymorphic form...
Invention Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitol. Methods of treating a s...
Invention Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitol. Methods of treating a sub...
2013 Invention Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin. The described invention...
2012 Invention Glufosfamide combination therapies for cancer. The invention provides compositions and methods fo...
Invention Glufosfamide combination therapies for cancer. The invention provides compositions and methods f...